3-Bromopyruvic acid

CAS No. 1113-59-3

3-Bromopyruvic acid( Bromopyruvic acid | Hexokinase II Inhibitor II 3-BP )

Catalog No. M20515 CAS No. 1113-59-3

3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 38 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    3-Bromopyruvic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
  • Description
    3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
  • In Vitro
    Cell Viability Assay Cell Line:MCF-7 and MDA-MB-231 cells Concentration:40, 80, 160 or 320 μM Incubation Time:24 hours Result:3-Bromopyruvate (80 and 160 μmol/l) and TRAIL (400 ng/ml) significantly inhibited cell viability.
  • In Vivo
    Animal Model:Female nude mice (BALB/c; 4-5-weeks old and 18-20 g)Dosage:8 mg/kg Administration:I.p.; every 4 days for 28 days Result:Showed antitumor efficacy in tumor xenografts.
  • Synonyms
    Bromopyruvic acid | Hexokinase II Inhibitor II 3-BP
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hexokinase II
  • Research Area
    Cancer
  • Indication
    antineoplastic

Chemical Information

  • CAS Number
    1113-59-3
  • Formula Weight
    166.96
  • Molecular Formula
    C3H3BrO3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:32 mg/mL (191.66 mM)
  • SMILES
    OC(=O)C(=O)CBr
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Leng X Peng J Yu X et al. 3-Bromopyruvic Acid A Hexokinase II Inhibitor is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) 2014 14(5):-.
molnova catalog
related products
  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • Lucidenic acid O

    Lucidenic acid O is a terpene compound, is a DNA polymerases inhibitor. Lucidenic lactone inhibits calf DNA polymerase-α, rat DNA polymerase-β, and HIV-1 reverse transcriptase with IC50 values of 42 μM, 99 μM, and 69 μM, respectively.

  • NCGC00229600

    NCGC00229600 is an allosteric inverse thyrotropin receptor (TSHR) agonist.